Rebecca Forman
Biographic Data
| ID | 5066331 |
|---|---|
| NAME | Rebecca Forman |
| GIVEN NAMES | Rebecca |
| FAMILY NAME | Forman |
| SIGNATURE | FORMAN R |
| AFFILIATIONS | London School of Economics and Political Science |
| ORCID | 0000-0002-0124-9997 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 2 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
The launch of the EU Health Emergency Preparedness and Response Authority (Hera): Improving global pandemic preparedness
The crowded global health landscape has been joined by the European Union Health Emergency Preparedness and Response Authority (HERA). HERA will assume four broad areas of responsibility: horizon scanning for major health threats; research and development; support for capacity to manufacture drugs, vaccines, and equipment; and procuring and stockpiling key medical countermeasures. In this Health Reform Monitor article, we outline the reform proce…
Drawing light from the pandemic: Rethinking strategies for health policy and beyond
Another crisis in the sorrowland: Covid-19 in northeast Syria
While for many countries, the management of COVID-19 has been well-documented, less is known about the response efforts in war and conflict-stricken areas such as North-East Syria (NES). NES was forced to confront SARS-CoV-2 amidst a slew of existing crises [1]. As it reaches its tenth year, the Syrian conflict remains one of the largest, [...]
Covid-19 vaccine challenges: What have we learned so far and what remains to be done
Developing and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine has garnered immense global interest. Less than a year after COVID-19 was declared a pandemic, several vaccine candidates had received emergency use authorization across a range of countries. Despite this scientific breakthrough, the journey from vaccine discovery to global herd immunity against COVID-19 continues to present significant policy challenges that require a…
The EU Response to Covid‐19: From Reactive Policies to Strategic Decision‐Making
Like every region in the world, the EU struggled in its response to COVID-19 – particularly in 2020 when much was still unknown about the disease. The Global Health Security Index ranked several European Union (EU) countries – the Netherlands, Sweden, Denmark, Finland, France, Germany and Spain – among the 15 countries with the highest health security capabilities to respond to infectious disease outbreaks (Nuclear Threat Initiative and Johns Hop…
Lessons learned from the management of the coronavirus pandemic
The Coronavirus SARS-CoV-2 has spread rapidly since the first cases hit Wuhan, China at the end of 2019, and has now landed in almost every part of the world. By mid-February 2020, China, South Korea, Singapore, Taiwan, and - to some extent - Japan began to contain and control the spread of the virus, while conversely, cases increased rapidly in Europe and the United States. In response to the pandemic, many countries have had to introduce drasti…
The EU Response to Covid‐19: From Reactive Policies to Strategic Decision‐Making
Like every region in the world, the EU struggled in its response to COVID-19 – particularly in 2020 when much was still unknown about the disease. The Global Health Security Index ranked several European Union (EU) countries – the Netherlands, Sweden, Denmark, Finland, France, Germany and Spain – among the 15 countries with the highest health security capabilities to respond to infectious disease outbreaks (Nuclear Threat Initiative and Johns Hop…
Lessons learned from the management of the coronavirus pandemic
The Coronavirus SARS-CoV-2 has spread rapidly since the first cases hit Wuhan, China at the end of 2019, and has now landed in almost every part of the world. By mid-February 2020, China, South Korea, Singapore, Taiwan, and - to some extent - Japan began to contain and control the spread of the virus, while conversely, cases increased rapidly in Europe and the United States. In response to the pandemic, many countries have had to introduce drasti…
Covid-19 vaccine challenges: What have we learned so far and what remains to be done
Developing and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine has garnered immense global interest. Less than a year after COVID-19 was declared a pandemic, several vaccine candidates had received emergency use authorization across a range of countries. Despite this scientific breakthrough, the journey from vaccine discovery to global herd immunity against COVID-19 continues to present significant policy challenges that require a…
The EU Response to Covid‐19: From Reactive Policies to Strategic Decision‐Making
Like every region in the world, the EU struggled in its response to COVID-19 – particularly in 2020 when much was still unknown about the disease. The Global Health Security Index ranked several European Union (EU) countries – the Netherlands, Sweden, Denmark, Finland, France, Germany and Spain – among the 15 countries with the highest health security capabilities to respond to infectious disease outbreaks (Nuclear Threat Initiative and Johns Hop…
Drawing light from the pandemic: Rethinking strategies for health policy and beyond
Another crisis in the sorrowland: Covid-19 in northeast Syria
While for many countries, the management of COVID-19 has been well-documented, less is known about the response efforts in war and conflict-stricken areas such as North-East Syria (NES). NES was forced to confront SARS-CoV-2 amidst a slew of existing crises [1]. As it reaches its tenth year, the Syrian conflict remains one of the largest, [...]
The launch of the EU Health Emergency Preparedness and Response Authority (Hera): Improving global pandemic preparedness
The crowded global health landscape has been joined by the European Union Health Emergency Preparedness and Response Authority (HERA). HERA will assume four broad areas of responsibility: horizon scanning for major health threats; research and development; support for capacity to manufacture drugs, vaccines, and equipment; and procuring and stockpiling key medical countermeasures. In this Health Reform Monitor article, we outline the reform proce…
Medicine (6 works) · Pandemic (6 works) · Political science (6 works) · Business (5 works) · Law (5 works) · Economic growth (4 works) · Economics (4 works) · Geography (3 works) · Global health (3 works) · Health care (3 works)